Overview Financials News + Filings Key Docs Charts Ownership Insiders |
Gritstone bio, Inc. (GRTS)
|
Add to portfolio |
|
|
Price: |
$7.02
| | Metrics |
OS: |
93.1
|
M
| |
|
|
Market cap: |
$653
|
M
| |
|
|
Net cash:
|
$41.4
|
M
| |
$0.44
|
per share
|
EV:
|
$612
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
|
| |
|
|
EBIT
|
($141)
|
M
| |
|
|
EPS |
$296.37
| |
0.0
|
x P/E
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-05-22 | Dec-31-21 | Dec-05-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
Revenues | 19.9 | 19.9 | 48.2 | 48.2 | 4.0 | 4.4 | 1.2 | 0.0 |
Revenue growth | -58.6% | -58.6% | 1094.3% | | -7.5% | 267.7% | | |
Cost of goods sold | 0.0 | 140.4 | 0.0 | 123.4 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross profit | 19.9 | -120.4 | 48.2 | -75.2 | 4.0 | 4.4 | 1.2 | 0.0 |
Gross margin | 100.0% | -603.8% | 100.0% | -156.0% | 100.0% | 100.0% | 100.0% | |
Selling, general and administrative | 140.4 | | 123.4 | | 110.1 | 102.3 | | |
Research and development | | | | | | | 55.0 | 35.7 |
General and administrative | | 29.0 | | 25.9 | | | 11.8 | 6.1 |
EBIT | -120.4 | -120.4 | -75.2 | -75.2 | -106.0 | -97.9 | -65.6 | -41.8 |
EBIT margin | -603.8% | -603.8% | -156.0% | -156.0% | -2626.1% | -2243.8% | -5525.2% | |
Pre-tax income | 0.0 | -119.7 | 0.0 | -75.1 | 0.0 | 0.0 | -64.8 | -41.4 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | | 0.0% | | 0.0% | | | 0.0% | 0.0% |
Net income | 0.0 | -119.7 | 0.0 | -75.1 | 0.0 | 0.0 | -64.8 | -41.4 |
Net margin | 0.0% | -600.1% | 0.0% | -155.7% | 0.0% | 0.0% | -5457.0% | |
|
Diluted EPS | $0.00 | ($1.32) | $0.00 | ($0.95) | $0.00 | $0.00 | ($7.26) | ($20.70) |
Shares outstanding (diluted) | 90.9 | 90.9 | 78.9 | 78.9 | 37.8 | 33.6 | 8.9 | 2.0 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|